Scarica l'app Stockscreener
9.27
4.73%
-0.46
Dopo l'orario di chiusura:
9.27
Precedente Chiudi:
$9.73
Aprire:
$9.48
Volume 24 ore:
2,452
Relative Volume:
0.01
Capitalizzazione di mercato:
$4.89M
Reddito:
-
Utile/perdita netta:
$-8.28M
Rapporto P/E:
-1.6673
EPS:
-5.56
Flusso di cassa netto:
$-7.99M
1 W Prestazione:
+6.55%
1M Prestazione:
-5.98%
6M Prestazione:
-51.84%
1 anno Prestazione:
-55.11%
Intervallo 1D:
$9.2101
$9.60
Intervallo di 1 settimana:
$8.06
$9.86
Portata 52W:
$5.01
$54.95
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Company Profile
Nome
Quoin Pharmaceuticals Ltd Adr
Settore
Industria
Telefono
97299741444
Indirizzo
23 HATA'AS STREET, KFAR SABA
Confronta QNRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QNRX
Quoin Pharmaceuticals Ltd Adr
|
9.27 | 4.89M | 0 | -8.28M | -7.99M | -5.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Quoin Pharmaceuticals Ltd Adr Borsa (QNRX) Ultime notizie
Quoin announces FDA clearance to initiate second whole body QRX003 NS study - TipRanks
FDA clears Quoin’s new Netherton syndrome study By Investing.com - Investing.com South Africa
FDA clears Quoin’s new Netherton syndrome study - Investing.com
Quoin Pharmaceuticals announces EMA grants ODD for QRX003 - TipRanks
Retail Buzz Intensifies Around Quoin Pharma Stock After Positive Pediatric Skin Study Data By Stocktwits - Investing.com India
Why Quoin Pharmaceuticals (QNRX) Stock Is Exploding Higher Wednesday - Benzinga
Quoin Pharmaceuticals announces initial positive clinical data for QRX003 - TipRanks
Quoin reports progress in pediatric skin disorder study By Investing.com - Investing.com India
Quoin Pharmaceuticals reports Q1 EPS ($6.50) vs ($38.73) last year - TipRanks
Quoin Pharmaceuticals regains Nasdaq compliance By Investing.com - Investing.com India
Quoin Pharmaceuticals regains Nasdaq compliance - Investing.com
Quoin Pharmaceuticals regains compliance with Nasdaq minimum bid price rule - TipRanks
Quoin Pharmaceuticals regains Nasdaq compliance with bid price - Investing.com
Quoin Pharmaceuticals releases second episode of ‘Living with Netherton’ series - TipRanks
QNRX Stock Plummets to 52-Week Low of $0.17 Amid Market Struggles - Investing.com India
Upcoming Stock Splits This Week (April 7 to April 11) – Stay Invested - markets.businessinsider.com
Quoin Pharmaceuticals announces ADS ratio change to meet Nasdaq requirements By Investing.com - Investing.com South Africa
Quoin Pharmaceuticals announces ADS ratio change to meet Nasdaq requirements - Investing.com
Quoin Pharmaceuticals reports positive clinical data for rare disease treatment - Investing.com India
Quoin Pharmaceuticals reports positive clinical data for rare disease treatment By Investing.com - Investing.com South Africa
What Is Going On With Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX)? - stocksregister.com
QNRX Stock Plummets to 52-Week Low at $0.26 Amid Market Struggles By Investing.com - Investing.com South Africa
QNRX Stock Plummets to 52-Week Low at $0.26 Amid Market Struggles - Investing.com India
Quoin seeks patent for skin disease treatment QRX003 By Investing.com - Investing.com South Africa
Quoin seeks patent for skin disease treatment QRX003 - Investing.com India
QNRX Stock Plummets to 52-Week Low at $0.28 Amid Market Struggles - Investing.com India
QNRX Stock Plummets to 52-Week Low at $0.28 Amid Market Struggles By Investing.com - Investing.com South Africa
NVIDIA Corp (NVDA) Shares Up Despite Recent Market Volatility - The News Heater
Quoin Pharmaceuticals reports promising Netherton Syndrome treatment - Investing.com India
Stock Performance Spotlight: Quoin Pharmaceuticals Ltd ADR (QNRX) Ends the Day at 0.31, Down by -2.06 - The Dwinnex
Is Energy Services of America Corp (NASDAQ: ESOA) Poised For Further Gains At A 45.82% Distance From The Low? - Marketing Sentinel
Should You Expect Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) To Recover From Its 9.68% Gain From Highs? - Marketing Sentinel
Now Is The Time To Build A Position In Health In Tech Inc (NASDAQ:HIT) - Marketing Sentinel
After A Decline Of -818.6% From The High, Can Evaxion Biotech A/S ADR (NASDAQ: EVAX) Recover Quickly? - Marketing Sentinel
BTC Digital Ltd (NASDAQ: BTCT): Can A Stock Be Up 21.97% YTD, And Still Be A Loser - Marketing Sentinel
ScanTech AI Systems Inc (NASDAQ: STAI) Gain Of 9.66% Compared To 52-Week Low; YTD Fall -84.49% – What Should You Do Now? – Marketing Sentinel - Marketing Sentinel
Now Is The Time To Build A Position In SolarBank Corporation (NASDAQ:SUUN) - Marketing Sentinel
Aurora Mobile Ltd ADR (NASDAQ: JG) Stock Gained 83.28% Over A Month – Any Room To Run? - Marketing Sentinel
Now Is The Time To Build A Position In Atyr Pharma Inc (NASDAQ:ATYR) - Marketing Sentinel
Berry Global Group Inc [BERY] Records 200-Day SMA of $64.89 - Knox Daily
Quoin Pharmaceuticals Ltd ADR [QNRX] stock for 250,000 USD was acquired by Carter Denise P. - Knox Daily
INVZ Shares Experience Surge in Value - Knox Daily
Jefferies Financial Group Inc [JEF] Shares Rise 1.55 % on Thursday - Knox Daily
DHT Holdings Inc [DHT] Shares Jump Approximately 9.62% Over the Year - Knox Daily
Now Is The Time To Build A Position In American Battery Technology Company (NASDAQ:ABAT) - Marketing Sentinel
After Jumping 10.61% During The Past Week, Should You Still Buy Recursion Pharmaceuticals Inc (NASDAQ: RXRX)? - Marketing Sentinel
Beyond Inc (NYSE: BYON) Has Succeeded In Generating Interest In 2025, The Stock Is Up 87.02% Year-To-Date - Marketing Sentinel
Orangekloud Technology Inc (NASDAQ: ORKT) Up 58.11% From 52-Week Low; YTD Falls -50.99% – Here’s What To Do Now – Marketing Sentinel - Marketing Sentinel
Market cap of Captivision Inc [CAPT] reaches 33.99M – now what? - The DBT News
Citigroup lifts StoneCo Ltd [STNE] price estimate. Who else is bullish? - The DBT News
PDD Holdings Inc ADR (NASDAQ: PDD): How To Buy And When To Buy And Its Performance & Trends - Marketing Sentinel
Quoin Pharmaceuticals Ltd Adr Azioni (QNRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Quoin Pharmaceuticals Ltd Adr Azioni (QNRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Myers Michael | Chief Executive Officer |
Dec 23 '24 |
Buy |
0.45 |
555,556 |
250,000 |
602,808 |
| Dunn Gordon | Chief Financial Officer |
Dec 23 '24 |
Buy |
0.45 |
122,221 |
54,999 |
151,077 |
| Culverwell Anthony James | Director |
Dec 23 '24 |
Buy |
0.45 |
100,000 |
45,000 |
100,317 |
| Dunn Gordon | Chief Financial Officer |
Sep 10 '24 |
Buy |
0.81 |
20,000 |
16,200 |
28,856 |
| Dunn Gordon | Chief Financial Officer |
Sep 09 '24 |
Buy |
0.79 |
8,856 |
7,005 |
8,856 |
| Carter Denise P. | Chief Operating Officer |
Sep 04 '24 |
Buy |
0.78 |
31,813 |
24,912 |
47,092 |
| Carter Denise P. | Chief Operating Officer |
Sep 03 '24 |
Buy |
0.65 |
5,922 |
3,825 |
15,279 |
| Myers Michael | Chief Executive Officer |
Sep 04 '24 |
Buy |
0.77 |
37,094 |
28,421 |
47,252 |
| Myers Michael | Chief Executive Officer |
Sep 03 '24 |
Buy |
0.62 |
800 |
495 |
10,158 |
1.11%
1.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):